Drugs - Real World Outcomes·6 OctPCSK9 inhibitors usage in South China: A Multi-Center Real-World StudyStudy in peopleInterventionsPaper
The Lancet Regional Health Western Pacific·27 AugThe impact and evolution of environmental/occupational, behavioural, and metabolic risk factors on CVD burdens in the Asia-Pacific region from 1990 to 2023: a secondary analysis of the Global Burden of Disease Study 2023Computational studyCardiovascular diseasePaper
Journal of the American Heart Association·20 AugAssociations of Cardiovascular-Kidney-Metabolic Syndrome With All-Cause and Cardiovascular Death and the Progression of Cardiovascular-Kidney-Metabolic Syndrome Among Hong Kong Chinese People Over 2 DecadesCohort study of 1,912 peopleCardiovascular-kidney-metabolic syndromePaper
ENDO 2025 Abstract·23 OctSAT-250 Impact of Lipoprotein(a) on the Clinical Diagnosis of Familial Hypercholesterolaemia in ChineseStudy in peopleBiomarkersPaper